FDA Enforcement Class II Ongoing

Revogene SARS-CoV-2_IVD real-time RT-PCR test intended for the qualitative detection of RNA from SARSCoV-2 Catalog Number: 410700

Recall: Z-1008-2023 · Reported February 1, 2023

Enforcement

Recall Number
Z-1008-2023
Event ID
91356
Classification
Class II
Status
Ongoing
Product Type
Devices
Firm
Meridian Bioscience Inc
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
E-Mail
Report Date
February 1, 2023
Initiation Date
December 15, 2022
Classification Date
January 20, 2023
Address
3471 River Hills Dr, N/A, Cincinnati, OH, 45244-3023, United States

Description

Revogene SARS-CoV-2_IVD real-time RT-PCR test intended for the qualitative detection of RNA from SARSCoV-2 Catalog Number: 410700

Reason

Leakage of the original specimen from the plastic microfluidic cartridge (PIE), possibility that laboratory personnel may be exposed to aerosolized specimen containing SARS-CoV-2

Code Info

UDI: N/A Lot Numbers 410700P019, 410700P020, 410700P021, 410700P022, 410700P023, 410700P024, 410700P027

Distribution

US Nationwide distribution in the states of AZ, CA, IN, KS, KY, LA, MI, MN, NC, NY, OR, TX.

Quantity

92 kits